Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Teesha Downton"'
Autor:
Fiona H. Zhou, Teesha Downton, Allegra Freelander, Joshua Hurwitz, C. Elizabeth Caldon, Elgene Lim
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 11 (2023)
CDK4/6 inhibitors have become game-changers in the treatment of estrogen receptor-positive (ER+) breast cancer, and in combination with endocrine therapy are the standard of care first-line treatment for ER+/HER2-negative advanced breast cancer. Alth
Externí odkaz:
https://doaj.org/article/d41e010baccd4a00b62b7cf83e137075
Publikováno v:
Cancer Research. 83:OT2-10
HER2Pro: A Phase 1b dose de-escalation study of high dose prochlorperazine added to paclitaxel, trastuzumab and pertuzumab in patients with previously untreated HER2-positive metastatic breast cancer Authors Teesha Downton1,2, Emma Karlsen1, Katharin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0bcc8f3936245be7832bfbe16622612e
https://doi.org/10.1158/1538-7445.sabcs22-ot2-10-05
https://doi.org/10.1158/1538-7445.sabcs22-ot2-10-05
Publikováno v:
Drug Design, Development and Therapy. 16:2933-2948
Several endocrine therapies are currently available for the treatment of estrogen receptor (ER) positive breast cancer, but the clinical benefit of these agents is limited by endocrine therapy drug resistance. A common mechanism of endocrine therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0b9d02ddff2da711df5013229cc4876
https://doi.org/10.2147/dddt.s380925
https://doi.org/10.2147/dddt.s380925
Autor:
Teesha Downton, Davendra Segara, Andrew Ong, Janne Bingham, Emma-Kate Carson, Julia Chen, Kate Middleton, Geoffrey Lindeman, Andrew Parker, Elgene Lim
Publikováno v:
Cancer Research. 83:OT2-01
WinPro: A window of opportunity study of endocrine therapy with and without prometrium in postmenopausal women with early-stage hormone receptor-positive breast cancer Authors Teesha Downton1,2,3, Davendra Segara3, Andrew Ong4, Janne Bingham5, Emma-K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53764d166bc22d2cd9313a5efa9da9ae
https://doi.org/10.1158/1538-7445.sabcs22-ot2-01-10
https://doi.org/10.1158/1538-7445.sabcs22-ot2-01-10
Autor:
Derrick Ho Wai Siu, Robert Sean O'Neill, Carole A Harris, Justine Wang, Luke Ardolino, Teesha Downton, Matthew Tong, Jun Hee Hong, Venessa Chin, Philip R Clingan, Morteza Aghmesheh, Hussein Soudy
Publikováno v:
Immunotherapy. 14(7)
Immune checkpoint inhibitors have been incorporated into the treatment of various malignancies. An increasing body of literature is reporting rare but potentially fatal adverse events associated with these agents. In this case series, the authors rep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d1a6da22ab564a829288e9dd5bbb16b
https://pubmed.ncbi.nlm.nih.gov/35321560
https://pubmed.ncbi.nlm.nih.gov/35321560
Publikováno v:
BMJ Case Rep
An 18-year-old woman presented to our institution with fever, bilateral flank pain, headache and photophobia. She had a previous atrial septal defect (ASD) closure device inserted at the age of 9 years. Blood cultures on admission were positive forCo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::106258183ebd9374cfb56b87fc2c4dde
https://europepmc.org/articles/PMC6536175/
https://europepmc.org/articles/PMC6536175/
